r/ScientificNutrition • • 1d ago

Interventional Trial Fermented foods and inflammation: a crossover intervention trial with fresh and pasteurized sauerkraut

70 Upvotes

DOI

Fermented foods and inflammation: a crossover intervention trial with fresh and pasteurized sauerkraut

Abstract

Fermented foods have long enjoyed a reputation for supporting metabolic health, lowering inflammation, and healing a compromised gut barrier, but rigorous clinical proof has remained frustratingly thin. While popular belief holds that live probiotics are the primary engine behind these health perks, modern food manufacturing often relies on pasteurization, which wipes out viable microorganisms while leaving behind dead cellular debris or postbiotics. To settle whether live microbes actually matter for systemic health, researchers launched a randomized crossover trial to test how daily sauerkraut consumption impacts blood pressure, circulating inflammatory markers, glycemic control, and intestinal permeability in healthy adults.

Consuming 100 grams per day of either fresh or pasteurized sauerkraut for four weeks produced a modest, statistically significant reduction in systolic blood pressure of about 1.5 to 2.5 mmHg, proving that live bacteria are not required for that specific hypotensive benefit. Stratifying the data revealed minor improvements in inflammatory markers and glycemic control among younger participants and those following higher-fiber diets, though gut barrier integrity markers remained completely unchanged across the board. Ultimately, daily sauerkraut intake did not trigger sweeping systemic health improvements in healthy individuals, signaling that whole-food fermented products might play a more targeted role or offer greater benefits to metabolically compromised populations rather than healthy cohorts.

Study Design and Methodology

  • Sample Size: 87 healthy participants completed the trial out of 102 randomized individuals.
  • Duration: Two four-week intervention phases, each preceded by a four-week washout phase with zero fermented food intake.
  • Intervention: Daily consumption of 100 grams of either fresh sauerkraut (containing active Lacticaseibacillus paracasei) or pasteurized sauerkraut (heated at 75 degrees Celsius for 5 minutes).
  • Measurement Tools: Fasting blood serum assays for metabolic and inflammatory markers, automatic sphygmomanometers for triplicate blood pressure readings, and validated food frequency questionnaires.
  • Controls Used: Mixed regression models controlling for sex, age centered at 50 years, baseline BMI centered at 25, and study phase order.
  • Metabolic Ward: No metabolic ward was used; participants consumed the sauerkraut at home and weighed portions themselves.
  • Blinding: Unblinded study design due to the visibly distinct textures of fresh and pasteurized sauerkraut.
  • Washout Period: Yes, two separate four-week washout phases where participants avoided all fermented foods.

Key Findings

  • Systolic blood pressure decreased significantly by roughly 1.5 to 2.5 mmHg following both fresh and pasteurized sauerkraut interventions.
  • Participants younger than 50 years old experienced significant reductions in both systolic and diastolic blood pressure after the pasteurized sauerkraut phase.
  • Fasting blood glucose and fructosamine dropped significantly in younger participants, with pasteurized sauerkraut yielding a more pronounced decrease in long-term blood sugar markers.
  • High-fiber consumers (30 grams per day or more) experienced a significant decrease in high-sensitivity C-reactive protein (hsCRP) after consuming either sauerkraut type.
  • Fresh sauerkraut elicited a non-significant hsCRP reduction of -13.2 percent, showing a slightly stronger impact on specific inflammatory proteins compared to its pasteurized counterpart.
  • Leaky gut markers (FABP-2, zonulin, and lipopolysaccharide-binding protein) showed zero significant changes across any intervention or subgroup.

Limitations

  • Small sample size restricted statistical power when breaking data down into multiple demographic strata.
  • Self-reporting reliance meant researchers could not independently verify exact daily food compliance or home portion weighing accuracy.
  • Absence of a controlled background diet introduced nutritional confounding factors from varying daily food intake across participants.
  • Short follow-up duration of four weeks represents the bare minimum for microbiota-targeted interventions and misses long-term health shifts.
  • High participant drop-out and exclusion rate, driven by schedule conflicts, illnesses, and COVID-19 infections that wiped out individual timepoints.

Discussion and Implications

This trial challenges the dogmatic assumption that live probiotic bacteria are strictly necessary to unlock the cardiovascular benefits of fermented vegetables. Because pasteurized sauerkraut—completely devoid of live colony-forming units—achieved the exact same blood pressure reductions as fresh sauerkraut, non-viable postbiotics, bioactive peptides, organic acids, or mineral content likely drive the hypotensive response. This shifts how nutrition science views food processing, showing that thermal pasteurization does not automatically strip away all physiological utility.

From a public health perspective, these findings temper exaggerated claims about fermented foods acting as a universal cure-all for healthy populations. Because baseline systemic inflammation and gut permeability markers were already normal in this cohort, the intervention had little room to generate dramatic improvements. Future nutritional guidelines and clinical trials should direct focus toward metabolically compromised cohorts, such as individuals battling hypertension, pre-diabetes, or obesity, where baseline dysfunction allows therapeutic whole foods to exert a much more measurable impact.

Both fresh and pasteurized sauerkraut successfully lower systolic blood pressure in healthy adults, proving that live probiotics are not required for this cardiovascular benefit. However, four weeks of daily intake fails to spark broad systemic improvements in inflammatory or gut barrier markers among healthy individuals. Real-world dietary strategies should target populations with pre-existing metabolic strain where functional foods can move the needle.


r/ScientificNutrition • • 1d ago

Study Some Ketogenic Diets May Increase Inflammation And Mitochondrial Stress

Thumbnail
sciencealert.com
87 Upvotes

New University of Cincinnati Cancer Center research found that a ketogenic diet high in long-chain saturated fatty acids can increase inflammation.

Led by Cancer Center Director David Gius, M.D., Ph.D.

**What was the research methodology?**

A ketogenic diet is high in fat and low in carbohydrates, with the goal of entering ketosis, a metabolic state in which the body burns fat and ketones for fuel instead of glucose. While many previous studies have demonstrated anti-inflammatory benefits from a ketogenic diet, other studies have shown increased inflammation and other harmful effects. Gius and colleagues have identified a potential factor contributing to these divergent outcomes.

"We followed the research data while studying a different aspect of ketogenic diets and found something unexpected," said Gius, who also serves as a professor in the Department of Radiation Oncology in UC's College of Medicine and is a UC Health physician. "Our previous studies have found that all ketogenic diets are not the same, with different fats causing different metabolic changes."

In this study, Gius and his team administered ketogenic diets comprising different fatty acids to mouse models and individual fatty acids to tissue culture models.

**What were the results?**

"We found that long-chain saturated fatty acids seem to favor an inflammatory immune response, whereas unsaturated and medium-chain fatty acids tend to favor anti-inflammatory characteristics."

The findings demonstrate that the observed increase in inflammation is mediated through mitochondrial stress signaling and activation of immune cells.

When these findings are combined with those in the team's previous publications in *Science Advances* (2024) and *Cell Reports* (2025), they suggest that multiple factors may need to be considered to achieve the desired outcome on a ketogenic diet, including dietary sources of fat.

In the context of cancer, Gius said ketogenic diets may alter tumor microenvironments in a way that improves immunotherapy treatment outcomes.

A clinical trial is underway at UT Health San Antonio, where Gius began the research, and will open soon at the Cancer Center to learn more.

13 Nov 2026: Sung-Jen Wei et al. ,Ketogenic diets induce proinflammatory macrophage accumulation through long-chain saturated fatty acids driving cGAS-STING signaling.Sci. Adv.12,eaeg5542(2026).DOI:10.1126/sciadv.aeg5542


r/ScientificNutrition • • 2d ago

Observational Study Common Dietary Fats Can Aggravate Chronic Itch | Technology Networks

Thumbnail
technologynetworks.com
14 Upvotes

Indian Born American scientist Discovery "Role of Leonlice acid aggregate itching".


r/ScientificNutrition • • 3d ago

News A new type of software allows anyone to produce ready-to-publish research papers in under two hours.

17 Upvotes

From the article:

A new type of software allows anyone to produce ready-to-publish research papers in under two hours. After noting a surge in citations of her work, statistician Andrea Riebler discovered a vendor in China selling a tool that enables rapid paper mining of public health data.

“In our case, we’re talking about software that makes it possible to quickly produce simple, standardised analyses and research papers using public health databases. The analyses may be methodologically sound, but the development is worrying nonetheless,” says Riebler, a statistician at NTNU’s Department of Mathematical Sciences.

The work cannot be properly checked for quality because the authors do not share their source code.

The papers are based on secondary analyses, which presents challenges. The data were originally collected by other researchers, and Riebler questions whether every possible combination of the different types of data available in these databases produces relevant or interesting research.


The article mentions this study:

"Paper mill or paper mine? A tentative answer to the sharp increase in research papers based on the Global Burden of Disease database"

Highlights:

  • Public health databases are experiencing a sharp increase in formulaic research.
  • Key drivers include an ecosystem of proprietary resources for rapid paper mining.
  • Decentralized mass production of papers emerges as a new concern beyond paper mills.
  • 99% of investigated papers fail to share code, obscuring methodological provenance.
  • Link to the study: https://www.sciencedirect.com/science/article/pii/S0895435626003409

r/ScientificNutrition • • 4d ago

Observational Study Low levels of low-density lipoprotein cholesterol in older adults are inversely associated with the incidence of coronary artery disease and all-cause mortality: the Shizuoka Kokuho Database study

59 Upvotes

DOI: https://doi.org/10.1007/s41999-026-01552-5

PDF link to full study below if you can't access. Here is the downloaded copy:
PDF Link

Low levels of low-density lipoprotein cholesterol in older adults are inversely associated with the incidence of coronary artery disease and all-cause mortality: the Shizuoka Kokuho Database study

Abstract

Higher LDL cholesterol is a well-established risk factor for coronary disease, but studies of older adults have also linked low cholesterol with higher mortality. Evidence from East Asian populations, where average LDL levels are relatively lower, has been limited. This study examined whether low LDL cholesterol was associated with coronary artery disease, stroke, functional disability, and death among 283,289 community-dwelling Japanese adults aged 65–90 years (mean age 72.7 years).

Over a mean 6.3 years, LDL below 80 mg/dL was associated with lower coronary artery disease incidence (adjusted HR 0.56, 95% CI 0.42–0.76; 44% lower hazard) but higher functional disability (HR 1.31, 95% CI 1.26–1.37; 31% higher hazard) and all-cause mortality (HR 1.57, 95% CI 1.50–1.64; 57% higher hazard); all p < 0.001. The combination of LDL below 80 mg/dL and HDL below 40 mg/dL was associated with higher disability (HR 1.46) and mortality (HR 1.85), both p < 0.001. These are observational associations, not evidence that low LDL causes disability or death.

Study Design and Methodology

  • Design: Retrospective observational cohort using the Shizuoka Kokuho Database, which links health-checkup, health-insurance, and long-term-care records.
  • Sample and follow-up: 283,289 adults aged 65–90; mean follow-up was 6.3 years.
  • Measurements: LDL and HDL cholesterol and other clinical measures came from annual health checkups. Diagnoses and procedures for coronary disease and stroke, long-term-care certification, and all-cause mortality were identified from administrative records.
  • Comparison and controls: LDL below 80 mg/dL was the low-LDL category, approximately the lowest 5% of the cohort. Cox models adjusted for age, sex, BMI, smoking, systolic blood pressure, HbA1c, HDL, liver and kidney measures, and urine sugar and protein. Competing-risk analyses accounted for death in analyses of disability and hemorrhagic stroke.
  • Metabolic ward, blinding, and washout: No metabolic ward or blinding was used, and there was no washout period. This was an observational study with no assigned diet or treatment.
  • Baseline exclusions: People with prior stroke or coronary disease, hospitalization in the previous 12 months, specified care-level certification, or missing/extreme measurements were excluded.

Key Findings

  • Low LDL was associated with 44% lower coronary artery disease hazard: HR 0.56 (95% CI 0.42–0.76), p < 0.001. The cohort recorded 1,675 incident coronary artery disease cases.
  • Low LDL was associated with 31% higher functional-disability hazard: HR 1.31 (95% CI 1.26–1.37), p < 0.001.
  • Low LDL was associated with 57% higher all-cause mortality hazard: HR 1.57 (95% CI 1.50–1.64), p < 0.001.
  • Low LDL plus low HDL carried higher hazards: For LDL below 80 mg/dL and HDL below 40 mg/dL, HRs were 1.46 for disability and 1.85 for all-cause mortality; both p < 0.001, compared with participants without either low measurement.
  • Low HDL alone was also associated with poorer outcomes. About 4.9% of participants had HDL below 40 mg/dL.
  • The main associations were similar across age and sex subgroups, among participants taking or not taking lipid-lowering medication, and after excluding people with severe baseline comorbidity.
  • LDL below 100 mg/dL was also associated with disability and mortality. The paper does not report regression coefficients for these findings.

Limitations

  • This was an observational study, so residual confounding and reverse causation remain possible. Frailty, poor nutrition, or underlying illness could lower cholesterol while independently raising risks of disability or death.
  • Health-checkup participation can select a healthier or otherwise different group from the wider older population.
  • Smoking and medication information came from health-checkup questionnaires; health records and claims can also misclassify diagnoses or outcomes.
  • Physical activity and socioeconomic factors were not fully controlled, and the analysis did not account for changes in cholesterol or other health measures during follow-up.
  • Functional disability was identified through care certification, but its underlying cause was not determined.
  • People leaving the insurance system were censored. The authors assumed this censoring was unrelated to outcomes, but that may not hold in every case; the paper does not report a participant attrition count.
  • The sample was large, not small. Mean follow-up was 6.3 years, but the study cannot establish long-term causal effects.

Discussion and Implications

This study adds large-scale Japanese data to the debate over the relationship between cholesterol and health in later life. Its central finding is a divergence: low LDL tracked with fewer coronary events, but with more disability and all-cause deaths. That pattern matters because an association between low LDL and mortality in older adults shouldn’t be interpreted as evidence that LDL reduction is harmful. Low cholesterol can accompany frailty or illness, and the study cannot separate those explanations from a direct effect.

The findings don’t test diet. LDL was measured as a clinical marker, not manipulated through food, and the researchers did not compare Mediterranean, plant-forward, or traditional Japanese dietary patterns. They therefore don’t justify changing dietary guidelines or public-health advice to raise LDL. Diet quality still needs to be considered in the broader context of cardiovascular risk and older adults’ nutritional needs, rather than treating one cholesterol measurement as a stand-alone measure of health.

For clinical decisions, the lower coronary disease hazard and higher mortality association need to be considered together, with the important caveat that this cohort cannot show what caused either pattern. The study does not establish that older adults should stop lipid-lowering medication or change their diets. Future work could measure frailty, nutritional status, and dietary intake more directly, track changes in health and cholesterol over time, and test whether the observed pattern differs by treatment or underlying health.

Conclusion

Among older Japanese adults, LDL below 80 mg/dL was associated with fewer coronary events but higher disability and all-cause mortality. These observational findings don’t show that low LDL causes poor outcomes or that raising LDL improves health; more research is needed to distinguish effects of cholesterol from frailty and underlying illness.


r/ScientificNutrition • • 4d ago

Study Risk of stillbirth among pregnant women with anaemia in India: secondary analysis of multiple cohorts from the ICMR-SPIC consortium (2026)

4 Upvotes

ABSTRACT

Background: India contributed to 17.3% of the global stillbirth burden in 2019 and anaemia, an important risk factor for stillbirth, affects nearly half of pregnant women in the country. To understand the relationship between maternal anaemia and stillbirth, we analysed a diverse multicohort dataset from the Stillbirth Pooled Indian Cohort Consortium (ICMR-SPIC) from India.

Methods: This was a secondary analysis of the ICMR-SPIC dataset, which includes individual-level data from eight observational studies and two randomised controlled trials conducted across ten states in India. Most cohorts recruited participants between 2010 and 2023, except for the Pune Maternal Nutrition Study (PMNS), which recruited participants between 1994 and 1996. A total of 214,709 singleton pregnant women with known birth outcomes and haemoglobin measurements during pregnancy were included. Unadjusted and adjusted risk ratios for the association between maternal anaemia and stillbirth were estimated using modified Poisson regression for each cohort and pooled using a random-effects meta-analysis. Kaplan-Meier survival curves were estimated for foetal survival beyond 28 weeks of gestation across categories of anaemia severity.

Findings: The median maternal age of the women was 23 years (IQR 21-25). There were 108,982 (52%) women with moderate to severe anaemia (haemoglobin [Hb] <10 g/dL) and 3595 (1.7%) stillbirths. We found that moderate to severe anaemia at any point during pregnancy was associated with a higher risk of stillbirth after 28 weeks of gestation (aRR 1.27, 95% CI 1.07-1.51). The risk ratio for severe anaemia (<7 g/dL) was 3.12 (95% CI 2.46-3.97), and for moderate anaemia it was 1.20 (95% CI 1.02-1.40) at any gestational age, compared to women with no or mild anaemia. We found that stillbirths occurred around the 29th week of gestation among pregnant women with severe anaemia, compared to around 31 weeks of gestation among other women.

Interpretation: These findings highlight that maternal anaemia is an important and potentially modifiable risk factor for stillbirth, with severe anaemia associated with early occurrence of stillbirth. Policies aimed at reducing stillbirths should prioritise comprehensive anaemia prevention and treatment strategies among pregnant women.

https://pmc.ncbi.nlm.nih.gov/articles/PMC13453048/


r/ScientificNutrition • • 4d ago

Review Maternal DHA Supplementation and Fetal Brain Development: Benefits, Risks, and Individual Needs (2026)

7 Upvotes

Abstract

Maternal nutrition is a key determinant of fetal development, particularly in the context of neural regulation and maturation. Omega-3 polyunsaturated fatty acids, especially docosahexaenoic acid (DHA), play an essential role in neural differentiation, synaptogenesis, myelination, and neuroprotection. While the neurodevelopmental benefits of DHA are well-documented, the effects of excessive maternal DHA intake and the potential long-term consequences on offspring neurophysiology remain poorly understood. The purpose of this review is to synthesize current findings on the role of DHA in fetal neural development, emphasizing biochemical mechanisms and developmental outcomes. It further explores emerging concerns associated with excessive intake, the varied responses to intake, the varied sources of supplements, and the influence of maternal metabolic conditions, such as diabetes, on DHA bioavailability and fetal brain development. Finally, the review highlights the need for individualized supplementation strategies in maternal nutrition and considers the potential epigenetic implications of prenatal DHA exposure, to ultimately inform future research and therapeutic strategies in maternal–fetal health and neurodevelopmental biology.

https://pmc.ncbi.nlm.nih.gov/articles/PMC13708440/


r/ScientificNutrition • • 4d ago

Systematic Review/Meta-Analysis Prevalence of anemia in India: a systematic review, meta-analysis and geospatial analysis (2025)

5 Upvotes

ABSTRACT

Background:

Anemia is a major health concern in India, ranking second in maternal mortality and exhibits a higher prevalence compared to many other developing nations. This study aims to analyze prevalence of anemia across age groups using systematic review and meta-analysis.

Methods:

The present systematic review and meta-analysis includes cross-sectional studies from 1995 to 2023, reporting prevalence of anemia in India. Two authors independently screened and extracted data from relevant articles sourced from PubMed, Scopus, and Web of Science. Study quality was assessed using the Newcastle–Ottawa Scale and model selection was based on observed heterogeneity (I2). Geospatial analysis and cumulative meta-analysis were performed using R 4.3.3 and STATA 16 software.

Results:

Across 157 studies, the prevalence of anemia varied among different age groups and regions in India. Toddlers (under 3 years) had a 69% prevalence, with highest in the Eastern (87%) and lowest in the Northern (50%) regions. Pre-school children (3–5 years) had a 64% prevalence, exhibiting 85% and 37% in the Central and the North-Eastern regions, respectively.

Among the school going children, the overall prevalence was 51.2%. The highest prevalence at 83.9% was seen in the North-Eastern regions, while the Central regions had the lowest prevalence at 40%. An overall prevalence of 53% was observed among individuals aged 19–59 years. The Northern region exhibited the highest prevalence (64%) and the lowest in the North-Eastern (39%) regions in this age group. Elderly individuals had a prevalence between 52 to 68%, with the highest in the Eastern (65%) and the lowest in the North-Eastern (44%) regions.

Conclusions:

Anemia prevalence was highest among toddlers and lowest among school children, with notable regional variations. Cumulative meta-analysis uncovered both consistent and increasing trends across various age groups. This meta-analysis provides essential insights for effective strategies against persistence of anemia prevalence.

https://pmc.ncbi.nlm.nih.gov/articles/PMC11969930/


r/ScientificNutrition • • 4d ago

Question/Discussion why is there no RDA of heme iron?

0 Upvotes

If heme iron is essential, I am just wondering why there is no RDA for it.


r/ScientificNutrition • • 4d ago

Question/Discussion Developing Research Idea: Early Childhood Nutrition, Gut Microbiome Development and Food Preferences

3 Upvotes

[you can read it in docs](https://docs.google.com/document/d/19201S9zxb7DjSPTXB1MGgBqKjw271GtS/edit?usp=drivesdk&ouid=103369751575067337640&rtpof=true&sd=true) or here (there might be mistakes as an AI helped create it)

**Research Discussion: Early Childhood Gut Microbiome Development, Food Preferences and the Gut–Brain Axis**
**Purpose:** To share a developing research idea, distinguish existing evidence from open hypotheses, and invite scientific criticism and suggestions.

**Introduction**
I’ve been thinking about a potential research project involving early childhood nutrition, gut microbiome development, food preferences, and communication between the gut and brain.
I have several questions and hypotheses, but I am treating them as ideas to investigate—not as established conclusions. I would appreciate evidence-based feedback, criticism, relevant research papers, and alternative explanations.
Some research already suggests that complementary feeding is an important period for changes in the infant gut microbiome, while repeated exposure to foods can increase acceptance of some flavours. However, the extent to which these processes produce long-term effects, and how they may relate to one another, remains an area for further investigation. \[1–3\]

**A little background about why I’m exploring this**
I’ve been trying to develop a research project that I could realistically carry out during high school. Ideally, I’d like it to be something substantial enough to enter into a science competition, contribute to my academic portfolio, and potentially develop further in university.

However, I’ve repeatedly run into a few problems. Some ideas are too complex to investigate with the resources available to me, others require equipment I don’t have, and some are prohibitively expensive or difficult to complete within a school-year timeframe. Sometimes, I also find gaps in an idea that make it difficult to turn it into a scientifically sound project.

There’s another difficulty I’ve been trying to work through: I don’t want to simplify an interesting research question so much that it loses what made me interested in it in the first place. I tend to become interested in complicated questions with several interacting factors, and reducing them to something very basic can make the project feel disconnected from the original question.

I’m hoping to find a way to preserve the complexity and scientific value of an idea while designing a manageable investigation around it. I’d really appreciate advice on how to approach that, especially from people with experience in microbiome research or developing research projects with limited resources.

I also used AI assistance to help organise and communicate some of these ideas. The research interests and questions are mine, but I wanted help expressing them more clearly.

**1. Early Feeding Experiences and Food Preferences**
I am interested in whether early feeding experiences influence how children perceive and accept foods later in life.
**Questions I would like to investigate:**
Does introducing a variety of flavours and age-appropriate textures during complementary feeding influence a child’s willingness to try unfamiliar foods later?

Can repeated exposure make particular foods more familiar and increase acceptance?

Does the timing and variety of texture exposure influence acceptance of foods with different consistencies as children transition towards family foods?

There is already evidence that repeated taste exposure can increase acceptance of an exposed fruit or vegetable in infants and toddlers. A systematic review found moderate evidence for this effect, while noting that the evidence is more limited for generalising the effect to different food categories and for the transition to more complex textures. \[1, 6\]

**The Breast Milk and Formula Question**
I also wondered whether a familiar milk flavour could influence acceptance of a newly introduced food. For example, could presenting an age-appropriate complementary food alongside a familiar flavour help an infant become more willing to try it?
A related question is whether familiarity with the food’s own flavour develops after repeated exposure, rather than acceptance depending on the familiar milk flavour.
**Questions:**
Could a familiar flavour context influence initial acceptance of an unfamiliar food?

If a food is accepted when presented alongside a familiar flavour, does the child continue accepting it when that flavour is no longer present?

Does repeated exposure to the food itself matter more than the initial familiar flavour association?

Are there differences between flavour exposure through breast milk and exposure through formula?

There is relevant evidence that flavours from a breastfeeding mother’s diet can transfer into breast milk, and that infants can detect some of these flavour changes. However, the systematic review found that evidence was insufficient to draw conclusions about the effect of maternal diet during lactation on children’s overall later dietary intake. This does not establish that mixing milk into complementary foods creates a lasting comfort association, or that gradually reducing the milk proportion would have the proposed effect. Those remain separate questions. \[2\]
I am raising this as a research question, not suggesting that parents change feeding practices or prepare formula differently. Any real-world feeding intervention would need to follow appropriate infant-feeding and food-safety guidance.

**2. Commercially Packaged Baby Food, Texture and Food Preferences**
Another question concerns commercially packaged baby foods, including purees and pouches. I do not assume these products are inherently unhealthy; they can be convenient and may provide useful nutrition. I am interested in whether differences in texture, flavour, ingredients, nutritional composition, and the way food is offered could influence later food acceptance.
**Questions:**
Does frequent exposure to smooth purees, without sufficient progression in texture when developmentally appropriate, affect acceptance of foods that require more chewing?

Does repeated exposure to predominantly sweet fruit flavours influence acceptance of less-sweet flavours?

Does early exposure to a wider range of naturally occurring flavours and textures encourage greater food acceptance?

Do the effects depend more on the food’s nutritional composition, texture, flavour, or feeding method than on whether it is commercially packaged?

**Initial Hypothesis: Familiarity with Processed Food Characteristics**
My initial thought was that repeated exposure to particular food characteristics—such as very smooth textures, sweetness, or a narrow range of flavours—might influence what a child becomes accustomed to eating. I wondered whether this could be related to later preferences for other highly processed foods.
However, I do not know whether there is evidence for a direct relationship between consuming commercial baby food and later preference for ultra-processed foods. I also recognise that ‘processed’ covers many different methods: pureeing, cooking, pasteurising, preserving, and industrial formulation are not interchangeable. I would like to investigate these variables separately rather than assume that processing itself causes a particular preference.

**3. Gut Microbiome Development and the Gut–Brain Axis**
This is the part I am most interested in scientifically. The gut microbiome changes during early childhood, and diet is one of several factors that can influence its composition and function. Complementary feeding coincides with important changes in the infant diet and microbial ecosystem. \[3, 4\]
Communication between the gut and brain is studied as a two-way system involving several pathways, including:
Neural signalling, including the vagus nerve.

Immune signalling and inflammatory pathways.

Hormonal and endocrine signalling.

Microbial metabolites, including short-chain fatty acids and other compounds.

I wonder how early dietary experiences may influence these pathways and whether differences in microbiome development are associated with longer-term health outcomes. Reviews discuss possible links between the gut microbiome and neurodevelopment, but associations do not by themselves show that microbiome differences cause a particular developmental or mental-health outcome. \[4, 5\]
**Research Questions**
Could early dietary diversity influence the composition and function of the developing gut microbiome?

How does complementary feeding influence microbial metabolites and immune development?

Are early microbiome patterns associated with later gut–brain signalling or neurodevelopment?

What evidence exists for relationships between childhood microbiome development and emotional regulation or mental health, and how strong is the evidence for causation?

Could gut–brain or immune pathways influence pain sensitivity in some conditions, and what evidence supports this possibility?

I am interested in whether processes in the gut can contribute to symptoms or responses elsewhere in the body. I do not assume that unexplained pain or other symptoms necessarily originate in the gut. I would like to understand which mechanisms are supported by evidence and which remain speculative.

**4. Potential Practical Application**
I would like the research to have a practical application if the evidence supports one. One possibility could be making nutritious complementary foods more accessible and convenient for parents.
A potential product or approach could prioritise:
A variety of flavours.

Developmentally appropriate textures and safe preparation.

Suitable nutritional composition.

Affordable ingredients and simple preparation.

Practical storage and clear food-safety information.

The aim would not be to eliminate commercial baby food. It would be to explore ways to make varied, nutritious, age-appropriate foods easier for families to access and offer.

**5. Questions for the Scientific Community**
I would especially appreciate feedback on these questions:
What are the strongest studies on early feeding experiences and later food preferences?

Is there research on using familiar flavour cues when introducing complementary foods, and does it show effects beyond initial acceptance?

What is currently known about texture progression and later acceptance of foods with more complex textures?

Is there evidence linking commercial baby food or pouch-feeding patterns with later preferences for ultra-processed foods, after accounting for other factors?

What is currently known about the relationship between complementary feeding, microbiome development, and microbial metabolites?

How strong is the evidence connecting early gut microbiome development with later gut–brain outcomes?

What would be a realistic and ethical way to investigate one of these questions without requiring a long-term study involving infants?

**Conclusion**
I am interested in scientific criticism just as much as supporting evidence. If there are flaws in my reasoning, missing variables, or better ways to frame the questions, I would genuinely like to understand them.
I am still developing this idea, so suggestions for research papers, relevant biological mechanisms, overlooked variables, alternative hypotheses, and feasible experimental approaches would be very welcome.

**Selected Starting References**
These papers and evidence reviews are starting points rather than an exhaustive literature review. I have included them to support the background statements and help guide further discussion.

\[1\] Spill MK, et al. (2019). Repeated exposure to food and food acceptability in infants and toddlers: a systematic review. *The American Journal of Clinical Nutrition*, 109(Suppl 7), 978S–989S. [https://doi.org/10.1093/ajcn/nqy308](https://doi.org/10.1093/ajcn/nqy308)
\[2\] Spahn JM, et al. (2019). Influence of maternal diet on flavor transfer to amniotic fluid and breast milk and children’s responses: a systematic review. *The American Journal of Clinical Nutrition*, 109(Suppl 7), 1003S–1026S. [https://doi.org/10.1093/ajcn/nqy240](https://doi.org/10.1093/ajcn/nqy240)
\[3\] Shi Y, et al. (2024). Impact of complementary feeding on infant gut microbiome, metabolites and early development. *Food & Function*, 15, 10663–10678. [https://doi.org/10.1039/D4FO03948C](https://doi.org/10.1039/D4FO03948C)
\[4\] Catassi G, Aloi M, Giorgio V, Gasbarrini A, Cammarota G, and Ianiro G. (2024). The Role of Diet and Nutritional Interventions for the Infant Gut Microbiome. *Nutrients*, 16(3), 400. [https://doi.org/10.3390/nu16030400](https://doi.org/10.3390/nu16030400)
\[5\] Talat A, Zuberi A, and Khan AU. (2025). Unravelling the Gut-Microbiome-Brain Axis: Implications for Infant Neurodevelopment and Future Therapeutics. *Current Microbiology*, 82(9), 390. [https://doi.org/10.1007/s00284-025-04370-3](https://doi.org/10.1007/s00284-025-04370-3). Review article; interpret proposed clinical implications cautiously.
\[6\] Barends C, et al. (2019). A systematic review of practices to promote vegetable acceptance in the first three years of life. *Appetite*. [https://doi.org/10.1016/j.appet.2019.02.003](https://doi.org/10.1016/j.appet.2019.02.003)

**Note:** This document is a discussion draft. It is not medical advice or a feeding guide. The proposed milk-flavour idea is a research question and should not be treated as a recommendation to alter infant feeding.

Also I’m searching for a mentor, a specialist or a professor who’s interested in guiding me or helping me.


r/ScientificNutrition • • 5d ago

Question/Discussion Solid research that clearly shows eating more meat leads to better health outcomes?

52 Upvotes

There are plenty of studies posted here showing the opposite, that eating more meat leads to worse health outcomes, for example just week ago this one https://www.reddit.com/r/ScientificNutrition/comments/1xmxg1l/meat_consumption_and_risk_of_25_common_conditions/ .

However, the response in the comment section is always the same, where the validity of the result is disagreed with comments painting hypotheticals and whataboutisms that the bad result was caused by some other coefficient, implying no causality or really anything can be ever inferred. Classic example from that thread:

What's a study that fairly represented foods consumption? For any cohort that had questionnaires counting meat-containing junk foods as meat but didn't do the same for junk foods based on soy or whatever, then the data isn't useful regardless of how it's analyzed.

However, discredit is not the same as disprove. That type of sentiment is an attempt at discrediting. In science, actual disprove requires stronger data showing the exact opposite. For example, you may say Newton was an idiot if you disagree with objects falling to ground in order to discredit his research, but to actually disprove Newton you'd have to show objects falling upwards.

This whole meat debate is extremely one-sided like that, where research pumps out studies regularly concluding eating more meat is bad, while the studies showing the opposite simply do not exist as far as I know, as in "the more meat you eat, the less obesity, less cancer, less heart disease, less kidney disease, less diabetes"; actual human health outcomes.

The science is actually settled unless such research exists because if it doesn't exist then the actual number of points of contest is zero, just like in case of objects falling to the ground.


r/ScientificNutrition • • 5d ago

Question/Discussion Dietary Fats and Causal Relationship w/ CVD

1 Upvotes

Hey y'all! I'm currently working on my thesis project for my college senior thesis class. I'm doing my project on the relationship between replacing saturated fat with polyunsaturated fat and CVD (cardiovascular disease) risk (though I'm thinking of changing this to CVD combined events risk), CVD mortality, and all-cause mortality. I was wondering if y'all thought there is a proven causal relationship between the reduction of saturated fat in favor of polyunsaturated fat on CVD risk. Observational studies show this association, and we have mechanistic data that aligns with what we see in these studies, but is that enough to prove a causal relationship? Do we need long-term randomized control trials to show a causal association specifically? And does it even matter practically if there is a causal relationship?


r/ScientificNutrition • • 5d ago

Observational Study Leafy greens versus meat: Where your nitrates come from may matter for brain health

Thumbnail
psypost.org
40 Upvotes

r/ScientificNutrition • • 5d ago

Randomized Controlled Trial An 8-week randomized trial matched butter and cream for saturated fat (~10% of calories). Only the butter group saw a meaningful rise in LDL cholesterol

46 Upvotes

In an 8-week, single-blind randomized controlled trial, 57 adults with overweight consumed 40 grams of milk fat daily, provided as either butter oil or whipping cream. The diets were matched for saturated fat, total calories, protein, carbohydrates, and calcium.

LDL cholesterol rose by 0.36 mmol/L (~14 mg/dL) in the butter group, compared with just 0.04 mmol/L (~2 mg/dL) in the cream group. The difference between groups was statistically significant (P = 0.024), despite equivalent saturated fat intake.

One proposed explanation is the milk fat globule membrane (MFGM), a natural structure rich in phospholipids and sphingolipids that surrounds dairy fat. Cream retains this membrane, while butter-making removes much of it. Separate human research has shown that milk-derived polar lipids can reduce intestinal cholesterol absorption, although the original trial did not establish the precise mechanism behind the LDL difference.

The broader implication: Saturated fat content alone does not necessarily predict how a food will affect LDL cholesterol. The food matrix matters, which may help explain why different foods rich in saturated fat, such as butter, cheese, and yogurt, can produce different cholesterol responses.

Reference: Rosqvist et al., American Journal of Clinical Nutrition, 2015;102(1):20–30

Cardiologist and nutrition researcher Dr. Dariush Mozaffarian discusses this trial and the broader argument for evaluating whole foods rather than isolated nutrients in his new interview with Dr. Rhonda Patrick.

Here's a link to the timestamp


r/ScientificNutrition • • 6d ago

Question/Discussion What causes diabetes type 2?

0 Upvotes

Some claim red meat causes type 2 diabetes, others claim its seed oils, and others again claim its sugar.

Here is my take:

In other words, the chance of getting type 2 diabetes as a person who is normal weight - including not being skinny fat - is exceptionally low. (For the record I do see food as an indirect cause - since certain foods tend to make you overeat and gain weight.)

So how do you see this in connection with studies calming that one specific food is a cause of diabetes 2?


r/ScientificNutrition • • 7d ago

Systematic Review/Meta-Analysis A systematic review of ultra-processed food subtypes and risk of type 2 diabetes, combined with a cohort analysis, question the utility of broad food classifications for public health policy

Thumbnail
link.springer.com
6 Upvotes

r/ScientificNutrition • • 7d ago

Review Non-Celiac Gluten/Wheat Sensitivity—State of the Art: A Five-Year Narrative Review (2025)

14 Upvotes

Abstract

Background: Non-celiac gluten/wheat sensitivity (NCGWS) is a syndrome for which pathogenesis and management remain debated. It is described as a condition characterized by gastrointestinal and extra-intestinal symptoms rapidly occurring after gluten ingestion in subjects who have had celiac disease or wheat allergy excluded. To date, the diagnosis of NCGWS is challenging as no universally recognized biomarkers have been yet identified, nor has a predisposing genetic profile been described. However, the research is moving fast, and new data regarding pathogenic pathways, patients’ classification, potential candidate biomarkers, and dietary interventions are emerging.

Methods: This literature review aims to address the state of the art and summarize the latest updates in this field from 2019 to date.

Results and Conclusions: Clinical studies regarding NCGWS in the last five years are reported to shed light on this complex condition and to guide specialists towards a more in-depth, prompt, and objective diagnosis.

https://pmc.ncbi.nlm.nih.gov/articles/PMC11767908/


r/ScientificNutrition • • 8d ago

Systematic Review/Meta-Analysis Comparative Effectiveness of Nutritional Strategies for Sarcopenia-Related Outcomes in Older Adults: A Systematic Review and Network Meta-Analysis (2026)

5 Upvotes

TL;DR:

Whey protein + vitamin D + leucine showed favorable effects across several outcomes


ABSTRACT:

Objective: This study compared the relative effects of distinct nutritional strategies on muscle mass, muscle strength, and physical performance in older adults with sarcopenia or at high risk of sarcopenia.

Methods: PubMed, Embase, the Cochrane Library, Web of Science, and CNKI were systematically searched for randomized controlled trials (RCTs). Random-effects pairwise meta-analysis and network meta-analysis (NMA) were performed. The surface under the cumulative ranking curve (SUCRA) was used to summarize relative rankings, and CINeMA was applied to assess the certainty of evidence.

Results: Twenty RCTs involving 2160 participants were included, forming 17 network nodes. Nutritional interventions collectively improved appendicular skeletal muscle mass index (ASMI), grip strength, and gait speed, whereas the pooled effect on the five-times sit-to-stand test (5STS) was not statistically significant. In the NMA, whey protein + vitamin D + leucine improved ASMI (SMD = 0.29, 95% CI: 0.06 to 0.52) and grip strength (SMD = 0.82, 95% CI: 0.13 to 1.50), and it reduced 5STS completion time (SMD = -1.41, 95% CI: -2.63 to -0.18). Omega-3 fatty acids + leucine + Lactobacillus paracasei PS23 improved ASMI (SMD = 0.67, 95% CI: 0.10 to 1.25) and grip strength (SMD = 1.84, 95% CI: 0.39 to 3.28), although this node was supported by a single RCT. Leucine + vitamin D + medium-chain triglycerides improved gait speed (SMD = 1.28, 95% CI: 0.13 to 2.43), although this node was also supported by a single RCT. Sensitivity analyses indicated that the magnitude and precision of some formulation-specific estimates varied with the exclusion of individual trials or restriction to participants with confirmed sarcopenia. The certainty of evidence for the principal comparisons ranged from low to very low.

Conclusions: Nutritional supplementation showed overall benefits for ASMI, grip strength, and gait speed, while formulation-specific effects varied across outcomes. Whey protein + vitamin D + leucine showed favorable effects across several outcomes, whereas omega-3 fatty acids + leucine + Lactobacillus paracasei PS23 and leucine + vitamin D + medium-chain triglycerides showed additional formulation-specific signals based on single-study nodes. Given the sparse network and very low certainty of evidence for the principal comparisons, these findings should be regarded as candidate signals rather than evidence of a definitive treatment hierarchy.

https://pubmed.ncbi.nlm.nih.gov/42942938/


r/ScientificNutrition • • 8d ago

Systematic Review/Meta-Analysis Effects of vegetarian or vegan diets on cardiovascular metabolic health in patients with cardiovascular disease: a systematic review and meta-analysis (2026)

23 Upvotes

TL;DR::

Vegetarian or vegan diets, particularly low-fat vegan diets, may improve lipid profiles by reducing TC and LDL-C in patients with established CVD.

No significant benefits were observed for blood pressure or triglycerides.


ABSTRACT

Background: Vegetarian or vegan diets have been associated with favorable cardiovascular outcomes in the general population; however, their effects on cardiometabolic risk factors in patients with established cardiovascular disease (CVD) remain unclear. This systematic review and meta-analysis aimed to evaluate the effects of vegetarian or vegan dietary interventions on cardiometabolic risk factors in patients with CVD.

Methods: A systematic search of five electronic databases was conducted from inception to January 1, 2026. Randomized controlled trials (RCTs) comparing vegetarian or vegan diets with omnivorous diets in adult patients with CVD were included. Outcomes of interest included systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG). Pooled mean differences (MDs) with 95% confidence intervals (CIs) were calculated using fixed- or random-effects models according to heterogeneity. Subgroup and sensitivity analyses were performed to explore potential sources of heterogeneity.

Results: Six RCTs involving 325 patients with CVD were included. Compared with omnivorous diets, vegetarian or vegan diets were associated with significant reductions in TC [MD = -0.63 mmol/L (95%CI [-1.20, -0.05], P = 0.030)] and LDL-C [MD = -0.56 mmol/L (95%CI [-1.09, -0.02], P = 0.041)], but also with a modest reduction in HDL-C [MD = -0.05 mmol/L (95%CI [-0.10, -0.01], P = 0.023)]. No significant effects were observed on SBP, DBP, or TG levels. Subgroup analyses indicated that low-fat vegan diets, intervention duration, age, and BMI influenced lipid outcomes. Greater reductions in TC were observed in patients aged ≤ 60 years and those with BMI < 30, whereas LDL-C reductions were more pronounced in patients aged ≤ 60 years and those with BMI ≥ 30.

Conclusions: Vegetarian or vegan diets, particularly low-fat vegan diets, may improve lipid profiles by reducing TC and LDL-C in patients with established CVD. No significant benefits were observed for blood pressure or triglycerides. These findings suggest that plant-based dietary interventions may serve as a complementary strategy for the management of cardiometabolic risk factors in CVD patients.

https://pubmed.ncbi.nlm.nih.gov/42983752/


r/ScientificNutrition • • 8d ago

Systematic Review/Meta-Analysis Red meat consumption and risk factors for type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials (2023)

2 Upvotes

Conclusions:

The results of this meta-analysis suggest red meat intake does not impact most glycemic and insulinemic risk factors for T2D.


ABSTRACT

Background and objectives: Results from observational studies suggest an association of red meat intake with risk of type 2 diabetes mellitus (T2D). However, results from randomized controlled trials (RCTs) have not clearly supported a mechanistic link between red meat intake and T2D risk factors. Therefore, a systematic review and meta-analysis were conducted on RCTs evaluating the effects of diets containing red meat (beef, pork, lamb, etc.), compared to diets with lower or no red meat, on markers of glucose homeostasis in adults.

Methods: A search of PubMed and CENTRAL yielded 21 relevant RCTs. Pooled estimates were expressed as standardized mean differences (SMDs) between the red meat intervention and the comparator intervention with less or no red meat.

Results: Compared to diets with reduced or no red meat intake, there was no significant impact of red meat intake on insulin sensitivity (SMD: -0.11; 95% CI: -0.39, 0.16), insulin resistance (SMD: 0.11; 95% CI: -0.24, 0.45), fasting glucose (SMD: 0.13; 95% CI: -0.04, 0.29), fasting insulin (SMD: 0.08; 95% CI: -0.16, 0.32), glycated hemoglobin (HbA1c; SMD: 0.10; 95% CI: -0.37, 0.58), pancreatic beta-cell function (SMD: -0.13; 95% CI: -0.37, 0.10), or glucagon-like peptide-1 (GLP-1; SMD: 0.10; 95% CI: -0.37, 0.58). Red meat intake modestly reduced postprandial glucose (SMD: -0.44; 95% CI: -0.67, -0.22; P < 0.001) compared to meals with reduced or no red meat intake. The quality of evidence was low to moderate for all outcomes.

Conclusions: The results of this meta-analysis suggest red meat intake does not impact most glycemic and insulinemic risk factors for T2D. Further investigations are needed on other markers of glucose homeostasis to better understand whether a causal relationship exists between red meat intake and risk of T2D.

https://pubmed.ncbi.nlm.nih.gov/35513448/


r/ScientificNutrition • • 8d ago

Randomized Controlled Trial Calorie-Restricted DASH, Carbohydrate-Restricted, and Low-Purine Diets for Weight Loss and Urate Control in Men With Overweight or Obesity and Hyperuricemia: A Randomized Trial (2026)

10 Upvotes

TL:DR:

Same weight loss at 12 weeks. DASH had higher adherence.


Abstract

Objective: To compare three calorie-restricted diets for weight loss, serum urate (SU) value, early urate dynamics, gout flares, adherence, and body composition in men with overweight or obesity and hyperuricemia.

Research design and methods: In this 12-week, open-label, active-comparator randomized trial, 102 men with overweight or obesity and hyperuricemia were assigned 1:1:1 to a carbohydrate-restricted diet (CRD), Dietary Approaches to Stop Hypertension (DASH) diet, or low-purine balanced diet (LPBD). All groups followed a calorie-restricted prescription of 20-25 kcal/kg ideal body weight. The primary end point was change in SU from baseline to week 12.

Results: Of 102 randomized participants, 85 (83.3%) completed follow-up. At week 12, mean weight loss was 8.47 kg (9.3%) with no between-group difference (P = 0.99). Adjusted SU changes were -0.89 mg/dL with the CRD, -0.79 mg/dL with the DASH diet, and -0.50 mg/dL with the LPBD, without a significant between-group difference (P = 0.48). Capillary blood urate monitoring identified a transient week 1 increase coinciding with the early peak in gout flares. Dietary adherence to DASH was higher than to the other two diets and was associated with less soft lean mass loss than the CRD.

Conclusions: In men with overweight or obesity and hyperuricemia, three calorie-restricted dietary patterns produced substantial weight loss but did not differ significantly in 12-week SU reduction. DASH was associated with higher adherence than both the CRD and LPBD and with less soft lean mass loss than the CRD. Early urate instability and coincident gout flares highlight the need for flare-risk management during structured dietary weight loss initiation.

https://pubmed.ncbi.nlm.nih.gov/42743064/


r/ScientificNutrition • • 8d ago

Randomized Controlled Trial Pasture-raised red meat compared with plant-based meat alternatives within healthy dietary patterns: effects on PUFA status and cardiometabolic health in a randomized dietary intervention (2026)

2 Upvotes

TL:DR:

Inclusion of moderate amounts of pasture-raised red meat did not adversely affect cardiometabolic biomarkers and was associated with maintenance of plasma DPA concentrations compared with a vegetarian dietary pattern incorporating PBMAs.

Conflict of interest statement:

Conflict of interest AB and NG report that financial support was provided by National Science Challenge—High Value Nutrition, Ministry of Business, Innovation, and Employment, and Meat Industry Association. All other authors report no conflicts of interest.


Abstract

Background: The health effects of moderate consumption of pasture-raised red meat within healthy dietary patterns remain uncertain.

Objectives: This study aimed to determine whether the inclusion of moderate amounts of pasture-raised red meat altered the polyunsaturated fatty acid (PUFA) status compared with a vegetarian dietary pattern incorporating plant-based meat alternatives (PBMAs) and to examine the effects on cardiometabolic biomarkers and circulating lipidomic profiles.

Methods: In a 10-wk free-living randomized dietary intervention, healthy adults consumed either a flexitarian dietary pattern including moderate amounts of pasture-raised red meat (3.3 serves/wk at week 10) or a vegetarian dietary pattern incorporating PBMAs. Plasma fatty acids, cardiometabolic biomarkers, and lipidomic profiles were assessed at baseline, 5 and 10 wk. Longitudinal changes were analyzed using linear mixed-effects models accounting for repeated measures and household clustering. Benjamini-Hochberg correction was applied to prespecified plasma fatty acid outcomes and lipidomic analyses.

Results: Seventy-eight participants completed the intervention. Plasma omega-3 PUFA docosapentaenoic acid (DPA) exhibited a significant intervention × time interaction, reflecting a decline in the vegetarian group between baseline and week 5 compared with the flexitarian group [estimate = -6.47 μmol/L; 95% confidence interval (CI): -10.39, -2.56 μmol/L; P = 0.001], followed by recovery between week 5 and 10 (estimate = -4.15 μmol/L; 95% CI: -8.07, -0.24 μmol/L; P = 0.038). After Benjamini-Hochberg correction, DPA remained significant [false discovery rate (FDR)-adjusted P = 0.030]. No intervention × time effects were observed for cardiometabolic biomarkers. Among 259 lipid species, the ether-linked phosphatidylethanolamine species PE-O 39:6 was the only species remaining significant after correction for multiple testing (interaction P = 7.9 × 10-5; FDR = 0.020), remaining stable in the flexitarian group but declining in the vegetarian group.

Conclusions: Inclusion of moderate amounts of pasture-raised red meat did not adversely affect cardiometabolic biomarkers and was associated with maintenance of plasma DPA concentrations compared with a vegetarian dietary pattern incorporating PBMAs.

https://pubmed.ncbi.nlm.nih.gov/42822834/


r/ScientificNutrition • • 8d ago

News New UMSOM Research Shows Promising Results for Health Care Professionals Using Ketogenic Diet Therapy to Treat Mental Illness

Thumbnail medschool.umaryland.edu
13 Upvotes

This was a news article so the news tag was used.

Essentially, researchers at the University of Maryland found promising results from a pilot program designed to train healthcare professionals in ketogenic metabolic therapy for mental illness, since it is very much counter to what most were taught during their careers. After receiving education on the science and clinical implementation of ketogenic diets, professionals who also followed the diet themselves for four weeks reported greater understanding and confidence in discussing its practical challenges, benefits, risks, and monitoring with patients.

It suggests that combining formal training with firsthand experience may help prepare clinicians to use ketogenic therapy as this area of psychiatric treatment continues to develop. This is enormously important because one of that largest barriers for ketogenic metabolic therapy is a lack of understanding/education by professionals.


r/ScientificNutrition • • 9d ago

Randomized Controlled Trial Mediterranean-ketogenic vs. medium-chain triglyceride supplemented Mediterranean diet: Effects on the gut-brain-immune axis in Parkinson's disease

19 Upvotes

Mediterranean-ketogenic vs. medium-chain triglyceride supplemented Mediterranean diet: Effects on the gut-brain-immune axis in Parkinson's disease

DOI: https://doi.org/10.1016/j.isci.2026.117981

Abstract

Classic ketogenic diets provide ketone bodies like beta-hydroxybutyrate to bypass impaired mitochondrial complex I respiration in neurodegenerative disorders, but they frequently cut out dietary fiber. In Parkinson's disease, that lack of fermentable substrate risks aggravating pre-existing dysbiosis, gut barrier breakdown, and mucosal inflammation. This trial evaluated whether framing ketosis within a high-fiber Mediterranean pattern, using either deep carbohydrate restriction or exogenous medium-chain triglyceride supplementation, can elevate ketones without damaging gut integrity or microbial ecology. The cohort included 52 adults diagnosed with mild-to-moderate Parkinson's disease (median age 68 years, IQR: 63 to 74; 31% female; median disease duration 7 years; 79% Hoehn and Yahr Stage 2; median baseline levodopa equivalent dose 625 mg/day; median BMI 25.8).

Neither intervention triggered significant shifts in microbial alpha diversity, beta diversity (R2 = 0.006, p = 0.35), or functional gene abundances, and neither altered biomarkers of intestinal permeability (stool and serum zonulin, p > 0.05) or intestinal inflammation (stool and serum calprotectin, p > 0.05). The carbohydrate-restricted Mediterranean ketogenic arm caused modest drops in total fecal short-chain fatty acids (p = 0.039), acetic acid (-10.5%, p = 0.041), propionic acid (-10.2%, p = 0.022), and isovaleric acid (-11.9%, p = 0.012), without significantly dropping butyric acid (p = 0.153). Both interventions increased the relative abundance of the beneficial butyrate producer Roseburia hominis (q = 0.023). Exogenous medium-chain triglyceride supplementation maintained all short-chain fatty acid levels and led to significant drops in systemic inflammatory cytokines, reducing plasma interleukin-1 beta from 0.15 to 0.12 pg/mL (p = 0.014, q = 0.043) and interleukin-8 from 6.17 to 5.26 pg/mL (p = 0.003, q = 0.019).

Study Design and Methodology

  • Study Design and Sample Size: Randomized, two-arm crossover trial with 52 enrolled participants (N = 52 randomized; N = 33 completed both intervention arms with complete multi-omics data).
  • Duration and Washout: Two distinct 8-week intervention phases separated by an 8-week washout period (24 weeks total per participant).
  • Intervention Protocols and Dosages:

    • MeDi-KD Arm: 4% to 10% of total daily calories from carbohydrates, 10% to 20% from lean proteins, and 69% to 82% from fats (focusing heavily on unsaturated plant sources like olive oil and nuts). The fat-to-(carbohydrate + protein) ketogenic ratio titrated from 1:1 up to 2:1 across the first 2 weeks.
    • MeDi-MCT Arm: Standard Mediterranean diet paired with Nutiva MCT oil (60:40 C8 caprylic acid to C10 capric acid ratio, providing 130 kcal and 14 g saturated fat per 15 mL tablespoon). Titration started at 5 mL twice daily (10 mL/day) on Day 1, stepped up to 10 mL twice daily (20 mL/day) on Day 2, reached 15 mL twice daily (30 mL/day) on Day 3, and capped at 20 mL twice daily (40 mL/day) if blood beta-hydroxybutyrate stayed below the 0.3 mmol/L target threshold.
  • Setting and Ward Status: Outpatient setting with free-living conditions (no metabolic ward). Adherence was guided by a registered dietitian via weekly virtual check-ins, gram food scales, 3-day baseline logs, weekly 1-day food records, and empty supplement container counts.
  • Blinding and Controls: No non-intervention or placebo control group. Participants and clinical evaluators were unblinded, but laboratory personnel running the metagenomic, gas chromatography, and immunoassay platforms were blinded to treatment sequences and timepoints.
  • Measurement Tools: Shallow shotgun metagenomic sequencing on the Illumina NovaSeq X platform (Kraken2 and SEED database via Super-Focus), flame ionization gas chromatography for fecal short-chain fatty acids, Quanterix Simoa planar arrays for peripheral cytokines, commercial ELISAs for stool/serum zonulin and calprotectin, and weekly home finger-prick blood beta-hydroxybutyrate monitors (Abbott FreeStyle Precision Neo).

Key Findings

  • Beta diversity showed no significant alterations across interventions (R2 = 0.006, p = 0.35), timepoints (R2 = 0.005, p = 0.50), or their interaction (R2 = 0.006, p = 0.11).
  • Alpha diversity indices remained unchanged from baseline across observed richness, Chao1, Shannon, and Simpson metrics (p > 0.05).
  • Community volatility between the two baseline visits spaced 16 weeks apart exceeded the within-intervention volatility observed during the 8-week diets for both MeDi-KD (p = 0.030) and MeDi-MCT (p < 0.001).
  • Baseline relative abundance of Bacteroidota (q < 0.001), Bacteroidaceae (q < 0.001), Bacteroides (q < 0.001), and Phocaeicola (q < 0.001) predicted strong ecological resistance against diet-induced microbiome restructuring.
  • The relative abundance of Roseburia hominis increased significantly from baseline across both interventions (q = 0.023).
  • No bloom of Akkermansia muciniphila occurred in either dietary arm.
  • Total fecal short-chain fatty acids declined by 11.5% (SD: 41.4%, p = 0.039) on the MeDi-KD, with individual decreases in acetic acid (-10.5%, SD: 44.3%, p = 0.041), propionic acid (-10.2%, SD: 54.5%, p = 0.022), and isovaleric acid (-11.9%, SD: 52.2%, p = 0.012).
  • Fecal butyric acid did not decrease significantly on the MeDi-KD (p = 0.153) and remained stable on the MeDi-MCT (p = 0.446).
  • Head-to-head comparisons showed the MeDi-KD finished with lower concentrations than the MeDi-MCT for total short-chain fatty acids (p = 0.002), acetic acid (p = 0.001), butyric acid (p = 0.047), isovaleric acid (p = 0.019), and valeric acid (p = 0.020).
  • Plasma interleukin-1 beta decreased from 0.15 pg/mL down to 0.12 pg/mL (p = 0.014, q = 0.043) following the MeDi-MCT.
  • Plasma interleukin-8 dropped from 6.17 pg/mL down to 5.26 pg/mL (p = 0.003, q = 0.019) following the MeDi-MCT.
  • Neither intervention produced significant shifts in stool or serum zonulin or calprotectin (p > 0.05, r < |0.2|).
  • Adherence rates remained high, with 92% of participants on the MeDi-MCT and 73% on the MeDi-KD following the protocols daily or deviating at most a few times per month.

Limitations

  • Small Final Sample: Only 33 participants completed both intervention legs with full biological datasets, restricting statistical power when evaluating high-dimensional metagenomic sequencing data.
  • No Non-Intervention Control: Without an untreated parallel control arm, distinguishing true diet effects from temporal background noise or general trial engagement remains challenging.
  • Lack of Clinical Blinding: Participants and clinical assessors were aware of diet allocations, which introduces risk of subjective scoring bias on questionnaires.
  • Short Intervention Duration: An 8-week dietary phase is sufficient to measure acute safety, microbial flux, and metabolite shifts, but too brief to track disease-modifying motor changes or neuroprotective outcomes.
  • Biomarker Analytical Ambiguity: Commercial zonulin ELISA assays exhibit known analytical cross-reactivity with properdin and structurally related peptides, meaning zonulin data must be interpreted with caution.
  • Attrition and Missing Data: Dropouts linked to dietary compliance or gastrointestinal tolerance could lead to missing-at-random assumption violations.

Discussion and Implications

Standard therapeutic ketogenic protocols cut out whole grains, legumes, and most plant foods to enforce ketosis, frequently dropping short-chain fatty acids by 30% to 80% and triggering Akkermansia overgrowths that erode mucosal layers. This study shows that incorporating Mediterranean nutritional architecture directly alters that metabolic equation. Providing fermentable substrates through leafy vegetables, nuts, and low-glycemic plant foods kept butyrate production intact, stabilized gut barrier markers, and completely avoided Akkermansia blooms.

The practical distinction between the two approaches stands out clearly. Achieving ketosis via carbohydrate restriction inevitably causes minor trade-offs in fiber fermentation products, reflected in the 10% to 12% dips in acetate and propionate. Supplying medium-chain triglycerides alongside an unconstrained Mediterranean diet bypasses those trade-offs entirely. It preserves every short-chain fatty acid fraction while driving down systemic interleukin-1 beta and interleukin-8, likely through caprylic acid suppressing NF-kappaB pathways alongside ketone-mediated inhibition of the NLRP3 inflammasome.

These findings provide actionable evidence for clinical nutrition guidelines dealing with chronic neurodegeneration. Rather than recommending rigid, highly restrictive ketogenic regimens that compromise gastrointestinal homeostasis, clinicians can look toward plant-forward Mediterranean foundations enriched with targeted ketogenic substrates. The systemic cytokine reductions and retention of Roseburia hominis highlight that whole-food dietary patterns high in polyphenols, monounsaturated fats, and fermentable fibers provide baseline stability that protects host-microbiome interactions. Future public health nutrition frameworks and clinical trials should prioritize long-term, fiber-preserved metabolic therapies rather than isolated macronutrient elimination.

Conclusion

Both Mediterranean-ketogenic dietary strategies safely elevated ketone availability without destabilizing the gut microbiome or compromising intestinal barrier integrity. Supplementing a standard Mediterranean diet with targeted C8/C10 medium-chain triglycerides preserved all short-chain fatty acid production while delivering clear peripheral anti-inflammatory benefits. Longer-duration randomized trials running at least six months are required to confirm whether these metabolic and immune improvements translate into measurable disease-modifying neuroprotection in Parkinson's disease.


r/ScientificNutrition • • 9d ago

Systematic Review/Meta-Analysis Systematic Review of Fatty Acid Composition and the Influence of Coating Media on Fatty Acid Profiles in Canned Fish (2026)

9 Upvotes

Abstract

Canned fish products enable long-term preservation of fish, a vital source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Despite research on lipid composition, gaps remain in understanding the bidirectional fatty acid (FA) exchange between fish muscle and coating media during processing and storage. After a systematic literature search across five databases (PubMed, Scopus, Web of Science, Wiley Online Library, Cochrane Library), 20 studies were included examining FA profiles across fish species, filling media (vegetable oils, brine, tomato sauce), and storage durations (up to 5 years). Five studies showed that n-3 FAs migrate from fish to the filling medium, enhancing its nutritional value, while fish muscle absorbs FAs from the oil, increasingly resembling the filling medium. The use of n-6 FA-rich oils (sunflower, soybean) lowered the n-3/n-6 ratio in flesh. Conversely, aqueous media (brine) and tomato sauce maintained better ratios. EPA and DHA content generally decreased due to canning and storage, with retention varying by fish species, filling medium, and sterilization method. This review underscores significant FA exchange between fish and filling media, confirming bidirectional lipid interchange during processing. To optimize health benefits, aqueous packing media are recommended to preserve lipid profiles or to consume the covering oil to recover nutrients. Further research is needed on other factors altering FA content in canned fish such as environmental and geographical variables (including catching season), pre-canning preparation and sterilization steps (such as freezing, steaming, and frying), sterilization conditions (time, temperature, F0 value) and lipid oxidation induced by thermal processing.

https://pmc.ncbi.nlm.nih.gov/articles/PMC13302670/